TrialMedical oncology (Northwood, London, England)2013

Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma.

Xuyuan Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.